UY40854A - Péptidos cíclicos dirigidos a fap y conjugados de los mismos - Google Patents
Péptidos cíclicos dirigidos a fap y conjugados de los mismosInfo
- Publication number
- UY40854A UY40854A UY0001040854A UY40854A UY40854A UY 40854 A UY40854 A UY 40854A UY 0001040854 A UY0001040854 A UY 0001040854A UY 40854 A UY40854 A UY 40854A UY 40854 A UY40854 A UY 40854A
- Authority
- UY
- Uruguay
- Prior art keywords
- fap
- cyclic peptides
- conjugates
- peptides directed
- imaging
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/008—Peptides; Proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Se describen en la presente péptidos cíclicos dirigidos a la proteína de activación de fibroblastos (FAP) y su incorporación en compuestos para la obtención de imágenes y terapias con radioligandos, así como métodos y/o usos de dichos compuestos para la obtención de imágenes, el tratamiento y/o la prevención de enfermedades y trastornos relacionados con la FAP.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363519599P | 2023-08-15 | 2023-08-15 | |
| US202463650139P | 2024-05-21 | 2024-05-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY40854A true UY40854A (es) | 2025-02-28 |
Family
ID=92712397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001040854A UY40854A (es) | 2023-08-15 | 2024-08-13 | Péptidos cíclicos dirigidos a fap y conjugados de los mismos |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20250090699A1 (es) |
| EP (1) | EP4762073A1 (es) |
| KR (1) | KR20260054703A (es) |
| CN (1) | CN121712789A (es) |
| AU (1) | AU2024326078A1 (es) |
| CL (1) | CL2026000382A1 (es) |
| CO (1) | CO2026001441A2 (es) |
| CR (1) | CR20260054A (es) |
| DO (1) | DOP2026000032A (es) |
| IL (1) | IL326227A (es) |
| MX (1) | MX2026001771A (es) |
| PE (1) | PE20260794A1 (es) |
| TW (1) | TW202508616A (es) |
| UY (1) | UY40854A (es) |
| WO (1) | WO2025037249A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026046340A1 (zh) * | 2024-08-30 | 2026-03-05 | 江苏恒瑞医药股份有限公司 | 一种f-18标记反应前体分子的方法 |
| WO2026163110A1 (en) * | 2025-01-30 | 2026-08-06 | Novartis Ag | Combinations with fap targeting compounds and conjugates thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2733117C (en) * | 2008-08-08 | 2016-03-22 | Polyphor Ag | Template-fixed peptidomimetics |
| PH12020551205A1 (en) | 2018-02-06 | 2021-04-19 | Univ Heidelberg | Fap inhibitors |
| CN116888138A (zh) * | 2020-11-30 | 2023-10-13 | 瑞择生物公司 | 放射性药物缀合组合物及其用途 |
-
2024
- 2024-08-13 UY UY0001040854A patent/UY40854A/es unknown
- 2024-08-13 WO PCT/IB2024/057866 patent/WO2025037249A1/en not_active Ceased
- 2024-08-13 IL IL326227A patent/IL326227A/en unknown
- 2024-08-13 US US18/802,972 patent/US20250090699A1/en active Pending
- 2024-08-13 AU AU2024326078A patent/AU2024326078A1/en active Pending
- 2024-08-13 PE PE2026000256A patent/PE20260794A1/es unknown
- 2024-08-13 KR KR1020267007566A patent/KR20260054703A/ko active Pending
- 2024-08-13 EP EP24768699.1A patent/EP4762073A1/en active Pending
- 2024-08-13 CN CN202480053830.2A patent/CN121712789A/zh active Pending
- 2024-08-13 CR CR20260054A patent/CR20260054A/es unknown
- 2024-08-13 TW TW113130304A patent/TW202508616A/zh unknown
-
2026
- 2026-02-09 CO CONC2026/0001441A patent/CO2026001441A2/es unknown
- 2026-02-09 CL CL2026000382A patent/CL2026000382A1/es unknown
- 2026-02-09 DO DO2026000032A patent/DOP2026000032A/es unknown
- 2026-02-12 MX MX2026001771A patent/MX2026001771A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CL2026000382A1 (es) | 2026-05-04 |
| WO2025037249A1 (en) | 2025-02-20 |
| CN121712789A (zh) | 2026-03-20 |
| AU2024326078A1 (en) | 2026-02-19 |
| US20250090699A1 (en) | 2025-03-20 |
| KR20260054703A (ko) | 2026-04-22 |
| IL326227A (en) | 2026-03-01 |
| PE20260794A1 (es) | 2026-04-08 |
| TW202508616A (zh) | 2025-03-01 |
| CR20260054A (es) | 2026-03-24 |
| MX2026001771A (es) | 2026-04-01 |
| CO2026001441A2 (es) | 2026-02-23 |
| DOP2026000032A (es) | 2026-03-15 |
| EP4762073A1 (en) | 2026-06-24 |